Emtricitabine And Tenofovir Disoproxil Fumarate Tablet, Film Coated
Product Images NDC 70710-1367

6 FDA label images from Zydus Pharmaceuticals Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Emtricitabine And Tenofovir Disoproxil Fumarate (NDC 70710-1367). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Aea4ca0a A4ee 4895 Ab93 010e118fa475 01)

Image (Aea4ca0a A4ee 4895 Ab93 010e118fa475 01)
Chemical structure of emtricitabine, one of the active ingredients in Emtricitabine and tenofovir disoproxil fumarate tablets. The diagram shows the molecular configuration featuring a fluorinated pyrimidine ring and a thiofuranose sugar moiety.*
FDA Label Image

Image (Aea4ca0a A4ee 4895 Ab93 010e118fa475 02)

Image (Aea4ca0a A4ee 4895 Ab93 010e118fa475 02)
Chemical structure diagram displaying the molecular composition of emtricitabine and tenofovir disoproxil fumarate, the active ingredients in the oral tablet formulation by Zydus Pharmaceuticals USA Inc.*
FDA Label Image

Image (Aea4ca0a A4ee 4895 Ab93 010e118fa475 03)

Image (Aea4ca0a A4ee 4895 Ab93 010e118fa475 03)
Packaging label for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets, 100 mg/150 mg film-coated tablets. The label indicates a 30-tablet bottle, prescription only, manufactured by Zydus Pharmaceuticals USA Inc. It includes dosage and storage information, child-resistant packaging note, and pharmacist dispensing instructions.*
FDA Label Image

Image (Aea4ca0a A4ee 4895 Ab93 010e118fa475 04)

Image (Aea4ca0a A4ee 4895 Ab93 010e118fa475 04)
Packaging label for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets, strength 133 mg/200 mg, film-coated oral tablets. The label indicates a package size of 30 tablets, labeled for prescription use only. Manufactured by Zydus Lifesciences Ltd. and distributed by Zydus Pharmaceuticals (USA) Inc. Additional details include dosage instructions, storage conditions, child-resistant packaging, and a pharmacist dispensing note for a Medication Guide.*
FDA Label Image

Image (Aea4ca0a A4ee 4895 Ab93 010e118fa475 05)

Image (Aea4ca0a A4ee 4895 Ab93 010e118fa475 05)
Label for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets, 167 mg/250 mg film-coated tablets, oral route. The label includes the NDC 70710-1366-3 and states the package contains 30 tablets for prescription use only. The labeler is Zydus Pharmaceuticals USA Inc., with manufacturing by Zydus Lifesciences Ltd., India, and packaging by Zydus Pharmaceuticals (USA) Inc., New Jersey. Child-resistant packaging and storage instructions are also provided.*
FDA Label Image

Image (Aea4ca0a A4ee 4895 Ab93 010e118fa475 06)

Image (Aea4ca0a A4ee 4895 Ab93 010e118fa475 06)
Label for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets 200 mg/300 mg film-coated tablets by Zydus Pharmaceuticals USA Inc. The package contains 30 tablets with Rx only designation. The label includes dosage details, storage instructions, and a pharmacist note to dispense the medication guide separately. Manufactured by Zydus Lifesciences Ltd., with distribution by Zydus Pharmaceuticals (USA) Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.